Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Food or edible as carrier for pharmaceutical
Reexamination Certificate
2006-02-07
2006-02-07
Page, Thurman K. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Food or edible as carrier for pharmaceutical
C424S434000, C424S435000
Reexamination Certificate
active
06994869
ABSTRACT:
The present invention relates to a nasogastric formulation comprising an amino acid source, a carbohydrate source, a lipid source, and a fatty acid delivery agent wherein the fatty acid has a bond hydrolysable in the colon to deliver free fatty acids such as short chain fatty acid acetate without having an adverse affect on the capacity to pass through a tube for tube feeding.
REFERENCES:
patent: 5723446 (1998-03-01), Gray et al.
patent: 5840860 (1998-11-01), Annison et al.
patent: 451750 (1991-10-01), None
patent: 04510750 (1996-11-01), None
patent: WO 95/13801 (1995-05-01), None
patent: WO 9608261 (1996-03-01), None
Caderni et al., “Dietary Sucrose, Glucose, Fructose, and Starches Affect Colonic Functions in Rats,” Nutrition and Cancer 1996, vol. 25, (No. 2), p. 179-184.
Bird Anthony R
Record Ian R
Topping David L
Ghali Isis
Page Thurman K.
Pillsbury Winthrop Shaw & Pittman LLP
The Commonwealth of Australia Commonwealth Scientific and Indust
LandOfFree
Nasogastric enteral formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nasogastric enteral formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nasogastric enteral formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3663968